Ethics, economics and the regulation and adoption of new medical devices: case studies in pelvic floor surgery

[1]  S. Athar.  Principles of Biomedical Ethics , 2011, The Journal of IMA.

[2]  Jeanne Lenzer,et al.  Watching over the medical device industry , 2009, BMJ : British Medical Journal.

[3]  Firouz Daneshgari,et al.  Re: FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence , 2009 .

[4]  Morgan E. Lim,et al.  Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand? , 2008, International Journal of Technology Assessment in Health Care.

[5]  C. Weijer,et al.  Ethical issues associated with the introduction of new surgical devices, or just because we can, doesn't mean we should. , 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[6]  Joel Lexchin,et al.  The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States , 2008, PLoS medicine.

[7]  J. Avorn.  Keeping science on top in drug evaluation. , 2007, The New England journal of medicine.

[8]  Vincent Richman,et al.  Ethical funds for physicians , 2007, Canadian Medical Association Journal.

[9]  B. Strom,et al.  The role of academia and the research community in assisting the food and drug administration to ensure U.S. drug safety , 2007, Pharmacoepidemiology and drug safety.

[10]  H. Krumholz,et al.  What have we learnt from Vioxx? , 2007, BMJ : British Medical Journal.

[11]  Bryn Williams-Jones,et al.  Mapping the integration of social and ethical issues in health technology assessment , 2007, International Journal of Technology Assessment in Health Care.

[12]  A. Gafni,et al.  Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. , 2006, Social science & medicine.

[13]  J. Bridges.  What can economics add to health technology assessment? Please not just another cost-effectiveness analysis! , 2006, Expert review of pharmacoeconomics & outcomes research.

[14]  Amiram Gafni,et al.  The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold , 2006, Journal of health services research & policy.

[15]  R. Steinbrook.  Financial conflicts of interest and the Food and Drug Administration's Advisory Committees. , 2005, The New England journal of medicine.

[16]  N. Wenger,et al.  New technology and the orthopaedic surgeon: are you protecting your patients? , 2004, Clinical orthopaedics and related research.

[17]  C. Weijer,et al.  When are research risks reasonable in relation to anticipated benefits? , 2004, Nature Medicine.

[18]  M. Cosson,et al.  Stress urinary incontinence surgery in the United States, L.E. Waetjen, L.L. Subak, H. Shen, F. Lin, T.H. Wang, E. Vittinghoff, J.S. Brown, in: Obstet Gynecol, 101. (2003), 671 , 2004 .

[19]  Amiram Gafni,et al.  Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. , 2003, Social science & medicine.

[20]  V A Minassian,et al.  Urinary incontinence as a worldwide problem , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  Feng Lin,et al.  Stress Urinary Incontinence Surgery in the United States , 2003, Obstetrics and gynecology.

[22]  A. Gafni,et al.  Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures? , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  Andreas Laupacis,et al.  Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones? , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  K. Luber,et al.  The demographics of pelvic floor disorders: current observations and future projections. , 2001, American journal of obstetrics and gynecology.

[25]  J. Gosby.  MEDIA REVIEWS: Basics of Qualitative Research - Techniques and Procedures for Developing Grounded Theory 2nd Edition by A. Strauss and J. Corbin. Sage Publications, , 2000 .

[26]  R. Winter.  Innovation in surgical technique. The story of spine surgery. , 2000, Clinical orthopaedics and related research.

[27]  M. Mugford,et al.  Elementary Economic Evaluation in Health Care , 1998 .

[28]  J. Colling,et al.  Epidemiology of Surgically Managed Pelvic Organ Prolapse and Urinary Incontinence , 1997, Obstetrics and gynecology.

[29]  P. Chisnall.  Qualitative Interviewing: The Art of Hearing Data , 1996 .

[30]  H. Snyder.  Qualitative interviewing: The art of hearing data , 1996 .

[31]  A Gafni,et al.  Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[32]  H. Rubin,et al.  Qualitative Interviewing (2nd ed.): The Art of Hearing Data , 2005 .

[33]  M. Bernstein,et al.  Surgical innovation or surgical evolution: an ethical and practical guide to handling novel neurosurgical procedures. , 2004, Journal of neurosurgery.

[34]  A Gafni,et al.  Opportunity costs and uncertainty in the economic evaluation of health care interventions. , 2002, Health economics.

[35]  Anselm L. Strauss,et al.  Basics of qualitative research : techniques and procedures for developing grounded theory , 1998 .

[36]  A. Strauss,et al.  The Discovery of Grounded Theory , 1967 .